Elicera Therapeutics Names Johan Liwing as CEO
Elicera Therapeutics appointed Johan Liwing as chief executive officer effective September 1, 2026. He succeeds co-founder Jamal El-Mosleh, who will remain employed through October 31 to provide an orderly handover. The transition follows Elicera’s…
